Identification of microR-106b as a prognostic biomarker of p53-like bladder cancers by ActMiR

Bladder cancers can be categorized into subtypes according to gene expression patterns. P53-like muscle-invasive bladder cancers are generally resistant to cisplatin-based chemotherapy, but exhibit heterogeneous clinical outcomes with a prognosis intermediate to that of the luminal and basal subtype...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Eunjee, Collazo-Lorduy, Ana, Castillo-Martin, Mireia, Gong, Yixuan, Wang, Li, Oh, William K., Galsky, Matthew D., Cordon-Cardo, Carlos, Zhu, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6212417/
https://www.ncbi.nlm.nih.gov/pubmed/29970902
http://dx.doi.org/10.1038/s41388-018-0367-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6212417/
https://www.ncbi.nlm.nih.gov/pubmed/29970902
http://dx.doi.org/10.1038/s41388-018-0367-0

Ejemplares similares